Location History:
- Itano, JP (1994)
- Tokushima, JP (1984 - 2007)
- Osaka, JP (2017)
Company Filing History:
5 out of 846 
1 out of 60 Years Active: 1984-2017
Title: Yasukazu Ohmoto: Innovator in Medical Diagnostics
Introduction
Yasukazu Ohmoto is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the measurement of antibodies and the development of therapeutic compositions. With a total of 5 patents to his name, Ohmoto's work has the potential to impact various obesity-related diseases.
Latest Patents
One of his latest patents is a method for measuring anti-WT1 antibodies. This invention allows for the measurement and evaluation of the anti-WT1 antibody in a sample with higher accuracy. The method utilizes specific polypeptides that have antigenicity to the anti-WT1 antibody, enhancing the reliability of the results. Another significant patent involves a smooth muscle growth inhibitory composition and a diagnostic method for arteriosclerosis. This invention includes a composition that comprises the adipose tissue-specific secretory factor apM1 as an active ingredient. It also provides a method for diagnosing arteriosclerosis by assaying apM1 in a sample, which can lead to the development of therapeutic and diagnostic methods for various diseases.
Career Highlights
Throughout his career, Yasukazu Ohmoto has worked with prominent organizations such as Otsuka Pharmaceutical Company and the International Institute of Cancer Immunology. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Ohmoto has collaborated with notable colleagues, including Yuji Matsuzawa and Fumio Shimizu. These partnerships have likely facilitated the advancement of his research and the successful development of his patents.
Conclusion
Yasukazu Ohmoto's contributions to medical diagnostics and therapeutic innovations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in the understanding and treatment of obesity-related diseases.